Zimmer Holdings has green light for acquisition of Biomet
Article continues below
This is a milestone combination.
David Dvorak, Zimmer president and CEO
The transaction, which is subject to customary closing conditions and regulatory approvals, is expected to close in the first quarter of 2015.
"This is a milestone combination that brings together two highly complementary organizations and is consistent with our mission to lead the industry in delivering value to healthcare providers, their patients and stockholders," David Dvorak, Zimmer president and CEO, said at the time.
The combined company will continue to be headquartered in Warsaw, Indiana, maintain regional offices around the world and is anticipated to preserve a long-term commitment to its talented team members. Upon completion of the transaction, David Dvorak will be President and Chief Executive Officer of the combined company. ■